AEON
AEON Biopharma, Inc.Company with tickers: AEON
CIK
1837607
CUSIP
00791X209
Shares Outstanding
26,307,211
13F Activity (30d)
20 filings
20 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $462,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $825,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-462,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-11,793,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $2.28 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $2.28 | USD/shares | 2025-03-31 | 10-Q | 2026-05-14 |